Condition
Digestive Health
Digestive health reflects how well your gut breaks down food, absorbs nutrients and signals your brain, with troubles like bloating, constipation or reflux. The evidence is strongest for senna and psyllium fiber, and trials of senna found intestinal motility went up. Those studies were small, though, with 165 people for senna, and its trials centered on constipation after childbirth or surgery.
Sources: PMID 6996138; PMID 20207340
- Supplements studied
- 16
- Medicines and peptides
- 1
- Graded outcomes
- 17
- Trials
- 26
- People studied
- 1,462
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Intestinal Motility Large Increase | Improves (the measure goes up) | Large effect | 8 studies | 165 people | ||
Studies that measured intestinal motility
| ||||||
| Constipation Signs and Symptoms Large Improvement | Improves (the measure goes down) | Large effect | 2 studies | 31 people | ||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fecal Weight Large Increase | Improves (the measure goes down) | Large effect | 3 studies | 47 people | ||
Studies that measured fecal weight | ||||||
| Intestinal Motility | Improves (the measure goes up) | 12 people | ||||
| Lipid Absorption | Improves (the measure goes up) | 4 people | ||||
Calcium
- Fecal Bile Acids: improves
- Lipid Absorption: improves
- Fecal Cholesterol: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fecal Bile Acids Small Increase | Improves (the measure goes up) | Small effect | 1 study | 48 people | ||
Studies that measured fecal bile acids | ||||||
| Lipid Absorption | Improves (the measure goes up) | 1 study | 13 people | |||
Studies that measured lipid absorption | ||||||
| Fecal Cholesterol | Changes; see studies | 35 people | ||||
| Fecal Water Genotoxicity | Changes; see studies | 35 people | ||||
Triphala (Emblica officinalis, Terminalia chebula, Terminalia bellirica)
- Constipation Relief: improves
- Gut Microbiome Modulation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Constipation Relief Clinical trial: 1 week treatment increased average weekly bowel frequency by 64.4%, and by 79.5% after 2 weeks. RCT: Triphala churna (3-6g at night with warm water) showed significant improvement in bowel parameters. Mild laxative effect without causing dependence, strengthens bowel musculature. | Improves (the measure goes up) | Moderate effect | ||||
| Gut Microbiome Modulation Double-blind RCT (PMID 32955913): Triphala supplementation showed trend toward decreased Firmicutes/Bacteroidetes ratio and increased Akkermansia muciniphila. Enhanced growth of beneficial Bifidobacteria and Lactobacillus while reducing harmful species. Increased short-chain fatty acid production, particularly butyrate. | Improves (the measure goes up) | Small effect |
Ginger (Zingiber officinale)
- Chemotherapy-Induced Vomiting: improves
- Postoperative Nausea/Vomiting: improves
- Gastric Emptying Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Chemotherapy-Induced Vomiting Meta-analysis (10 RCTs): OR 0.71 (95% CI 0.54-0.94, p=0.015) for CINV control. Systematic review update (18 articles): 60% reduced acute vomiting likelihood with ≤1g/day for >3 days vs control. Also reduced chemotherapy-related fatigue. Nausea results mixed due to clinical heterogeneity. | Improves (the measure goes down) | Moderate effect | ||||
| Postoperative Nausea/Vomiting Multiple systematic reviews: Ginger reduces PONV severity and decreases need for rescue antiemetics. Two of three RCTs found ginger superior to placebo and equally effective as metoclopramide. Typical dose: 1g before operation. Some meta-analyses show non-significant difference vs placebo. | Improves (the measure goes down) | Moderate effect | ||||
| Gastric Emptying Rate Small Increase | Improves (the measure goes up) | Small effect | 4 studies | 24 people | ||
| Gastric Emptying Multiple small studies suggest ginger promotes gastric motility and accelerates gastric emptying. May benefit functional dyspepsia and gastroparesis. Mechanism involves cholinergic stimulation and prostaglandin modulation. More research needed for clinical recommendations. | Improves (the measure goes up) | Small effect | ||||
| Lower Esophageal Pressure | Improves (the measure goes up) | 1 study | 14 people | |||
Studies that measured lower esophageal pressure | ||||||
Ephedrine
- Body Fat: improves
- Weight: improves
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Moderate Decrease | Improves (the measure goes down) | Moderate effect | 1 study | 167 people | ||
Studies that measured body fat | ||||||
| Weight | Improves (the measure goes down) | 9 studies | 167 people | |||
Studies that measured weight
| ||||||
| Heart Rate | Improves (the measure goes down) | 1 study | 167 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 167 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 167 people | ||||
Yacon
- Fecal Weight: improves
- Intestinal Motility: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fecal Weight Small Increase | Improves (the measure goes down) | Small effect | 1 study | 16 people | ||
Studies that measured fecal weight | ||||||
| Intestinal Motility | Improves (the measure goes up) | 16 people | ||||
Peppermint
- Colonic Tension: improves
- Pain: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Colonic Tension Small Improvement | Improves (the measure goes up) | Small effect | 65 people | |||
| Pain | Improves (the measure goes down) | 1 study | 65 people | |||
Lactobacillus reuteri
- Constipation Signs and Symptoms: improves
- Infant crying: improves
- Immunity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Constipation Signs and Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 468 people | |||
| Infant crying | Improves (the measure goes up) | 8 studies | 468 people | |||
Studies that measured infant crying
| ||||||
| Immunity | Improves (the measure goes up) | 1 study | 31 people | |||
| Lung Function | Improves (the measure goes up) | 1 study | 30 people | |||
| TNF-Alpha | Improves (the measure goes down) | 1 study | 30 people | |||
Studies that measured tnf-alpha | ||||||
| Interleukin 1-beta | Improves (the measure goes down) | 30 people | ||||
| Interleukin 10 | Improves (the measure goes up) | 30 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 30 people | ||||
| Interleukin 8 | Changes; see studies | 30 people | ||||
| Lipid Absorption | Improves (the measure goes up) | 30 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 31 people | ||||
| Monocyte Count | Improves (the measure goes up) | 31 people | ||||
| Weight | Improves (the measure goes down) | 30 people | ||||
Lactobacillus Casei
- Blood glucose
- Intestinal Permeability: improves
- Immunity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 28 people | ||||
| Intestinal Permeability | Improves (the measure goes up) | 1 study | 28 people | |||
Studies that measured intestinal permeability | ||||||
| Immunity | Improves (the measure goes up) | 28 people | ||||
| Weight | Improves (the measure goes down) | 28 people | ||||
Citrulline
- Blood Flow: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow | Improves (the measure goes up) | 2 studies | 10 people | |||
Fish Oil
- Intestinal Permeability: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Intestinal Permeability | Improves (the measure goes up) | 1 study | 200 people | |||
Studies that measured intestinal permeability | ||||||
Green Tea Extract
- Carbohydrate Absorption: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Carbohydrate Absorption | Improves (the measure goes up) | 1 study | 28 people |
Colostrum
- Intestinal Permeability: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Intestinal Permeability | Improves (the measure goes up) | 1 study | 22 people |
Curcumin
- Intestinal Motility: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Intestinal Motility | Improves (the measure goes up) | 1 study | 8 people |
Astaxanthin
- Inflammation: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Inflammation | Changes; see studies | 1 study | 44 people |
Prescription medicines and peptides studied, for context
Ipamorelin
- Gastric Motility: improves
- Postoperative Recovery
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Gastric Motility Ipamorelin demonstrated dose-dependent improvement in gastric emptying in rodent models of postoperative ileus, though human clinical trials showed no significant difference versus placebo. | Improves (the measure goes up) | Moderate effect | 5 studies | |||
| Postoperative Recovery In a randomized controlled trial of bowel resection patients, ipamorelin was well-tolerated but showed no significant differences versus placebo in time to first bowel movement or hospital discharge. | NoneNo effect | 4 studies |
What the published studies found
5 automated readings
Ginger (Zingiber officinale): bloating
The 3 studies read (121 people in all) mostly found an improvement in bloating. The evidence is limited.
3 studies counted of 8 read: 3 trials (121 people in the trials).
- Randomised trial, 2023; 52 people; patients with relapsing-remitting multiple sclerosis: improves.
severity (-11.57 ± 5.09 vs. 3.97 ± 3.99, P = 0.047) of bloating
The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial - Randomised trial, 2022; 50 people: improves.
upper abdominal bloating and early satiation was 64% in subjects receiving ONLP-06
A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Comparative Clinical Study to Evaluate the Efficacy and Safety of OLNP-06 versus Placebo in Subjects with Functional Dyspepsia - Crossover trial, 2011; 19 people; healthy male volunteers: no clear difference.
bloating, fullness, nausea, discomfort and hunger was not different
The effects of ginger on gallbladder motility in healthy male humans
- Randomised trial, 2023; 52 people; patients with relapsing-remitting multiple sclerosis: improves.
Peppermint: bloating
The studies read are too weak to tell whether Peppermint changes bloating. They lean toward an improvement, which is not enough to claim one. The evidence is very weak.
3 studies counted of 8 read: 2 trials (89 people in the trials).
- Study, 2025; patients with functional dyspepsia: improves. Updated document on the management of functional dyspepsia by the Asociación Española de Neurogastroenterologia y Motilidad (ASENEM) and Sociedad Española de Medicina Familiar y Comunitaria (semFYC)
- Randomised trial, 2024; 32 people: improves.
POCO induced less epigastric burning, bloating, and fullness
The combination of L-menthol and caraway oil does not affect gastric function but increases hunger in healthy subjects - Randomised trial, 2007; 57 people: improves.
statistically significant reduction of the total irritable bowel syndrome symptoms score
Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial
Probiotics: gastrointestinal symptoms
The studies disagree. A Cochrane review (2022, 5 studies, 250 people) did not settle it for gastrointestinal symptoms, while 8 of the 10 studies read found an improvement. The evidence is very weak.
10 studies counted of 11 read: 6 reviews and 4 trials (161 people in the trials).
- Systematic review, 2022; 5 studies, 250 people; solid organ transplant recipients: unclear: evidence too weak to tell (the review the verdict rests on).
Probiotics had uncertain effects on GI side effects
Synbiotics, prebiotics and probiotics for solid organ transplant recipients - Systematic review, 2026; 15 studies, 1,015 people; individuals with autism spectrum disorder: improves.
improvements in GI symptoms, such as reduced abdominal pain
Pre- and probiotics for gastrointestinal and behavioral symptoms in autism spectrum disorder: a systematic review - Meta-analysis, 2026; 28 studies; patients with Helicobacter pylori infection: improves. Evaluating probiotic monotherapy in Helicobacter pylori infection: A meta-analysis of randomized controlled trials with trial sequential analysis
- Meta-analysis, 2026; 12 studies; adults with colorectal cancer receiving chemotherapy: improves.
significantly reduced chemotherapy-related diarrhea (odds ratio 0.48
Comparative Effects of Microbiota-Modifying Interventions for Gastrointestinal Disorders in Adults with Colorectal Cancer: A Systematic Review and Network Meta-Analysis - Meta-analysis, 2025; 18 studies, 1,246 people: improves.
alleviated gastrointestinal disturbances, such as diarrhea
Research progress of probiotics intervention on reconstruction of intestinal flora and improvement of quality of life in patients after endometrial cancer surgery - Meta-analysis, 2015; 23 studies, 3,938 people; children receiving antibiotics: improves.
incidence of AAD in the probiotic group was 8%
Probiotics for the prevention of pediatric antibiotic-associated diarrhea - Randomised trial, 2025; 59 people; overweight and obese adults aged 20-40: improves.
alleviated symptoms such as gastroesophageal reflux
Impact of probiotic Lactobacillus plantarum GKM3 on gastrointestinal health in overweight and obese individuals: A randomized clinical trial - Randomised trial, 2025; 22 people; patients with irritable bowel syndrome with predominant diarrhea: improves. Colonoscopic administration of probiotics to treat irritable bowel syndrome with predominant diarrhea: a randomized placebo-controlled clinical trial
- Randomised trial, 2025; 16 people; female dancers: no clear difference.
No improvement in gastrointestinal symptoms was observed
A Randomized Controlled Trial Evaluating the Effects of a Probiotic Containing Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 on Gastrointestinal Symptoms and Metabolomic Profiles in Female Dancers - Randomised trial, 2017; 64 people; patients receiving aspirin for more than one month: improves.
FSSG and GSRS scores were also significantly improved
Yogurt Containing Lactobacillus gasseri Mitigates Aspirin-Induced Small Bowel Injuries: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
- Systematic review, 2022; 5 studies, 250 people; solid organ transplant recipients: unclear: evidence too weak to tell (the review the verdict rests on).
Probiotics: irritable bowel syndrome symptoms
A Cochrane review (2023, 18 studies, 1,309 people) found a large improvement in irritable bowel syndrome symptoms. That review studied children with functional abdominal pain disorders. 9 of the 11 studies read agree; 1 found no clear answer, 1 found no clear difference. The evidence is limited.
11 studies counted of 11 read: 11 reviews.
- Meta-analysis, 2023; 18 studies, 1,309 people; children with functional abdominal pain disorders: improves (the review the verdict rests on).
Probiotics may achieve more treatment success when compared with placebo
Probiotics for management of functional abdominal pain disorders in children - Meta-analysis, 2026; 12 studies, 1,303 people; patients with irritable bowel syndrome: improves.
Multistrain probiotics significantly reduced total IBS-SSS scores [mean difference = -43.66, 95% confidence interval (CI): …
Effect of multistrain probiotics on symptom severity in irritable bowel syndrome: a systematic review and meta-analysis of irritable bowel syndrome-symptom severity score outcomes - Meta-analysis, 2025; 16 studies, 2,823 people: improves.
Probiotics showed a clinically significant overall improvement
Efficacy of Specific Probiotic Strains in Subtypes of Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials - Systematic review, 2025; 44 studies; patients with irritable bowel syndrome: improves.
significantly lower effectiveness than the probiotics group
Effects of Probiotics and Diet Management in Patients With Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis - Meta-analysis, 2024; 23 studies, 3,288 people: improves. Efficacy of Probiotics in the Management of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
- Meta-analysis, 2024; 20 studies, 3,011 people: improves.
probiotics are more effective than placebo in reducing global IBS symptoms improvement rate
Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis - Meta-analysis, 2023; 72 studies; people with irritable bowel syndrome: improves.
significantly better overall effect of probiotics than placebo
Probiotics for the management of irritable bowel syndrome: a systematic review and three-level meta-analysis - Meta-analysis, 2022; 16 studies, 1,585 people; patients with diarrhea: improves. Meta-analysis of the efficacy of probiotics to treat diarrhea
- Meta-analysis, 2018; 53 studies, 5,545 people; adults with irritable bowel syndrome: unclear: evidence too weak to tell.
beneficial effects on global IBS symptoms and abdominal pain
Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome - Meta-analysis, 2017; 19 studies, 1,453 people; children with recurrent abdominal pain or irritable bowel syndrome: improves.
probiotics were more likely to experience improvement in pain
Dietary interventions for recurrent abdominal pain in childhood - Systematic review, 2009; 2 studies, 168 people; school-age children with recurrent abdominal pain: no clear difference. Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood
- Meta-analysis, 2023; 18 studies, 1,309 people; children with functional abdominal pain disorders: improves (the review the verdict rests on).
Probiotics: bloating
The best available review (2013, 37 studies) found an improvement in bloating. That review studied adults with lower gastrointestinal symptoms. 5 of the 7 studies read agree; 2 found no clear difference. The evidence is moderate.
7 studies counted of 11 read: 4 reviews and 3 trials (500 people in the trials).
- Systematic review, 2013; 37 studies; adults with lower gastrointestinal symptoms: improves (the review the verdict rests on).
reduce bloating/distension and improve bowel movement frequency/consistency in some IBS patients
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide - Systematic review, 2026; patients with irritable bowel syndrome: improves.
probiotics can modestly improve global symptoms, abdominal pain, and bloating in IBS
Clinical guidance and practical recommendations for probiotic use in patients with irritable bowel syndrome, functional constipation, and Clostridioides difficile infection considering sex-based differences: a Korean translation - Meta-analysis, 2024; 23 studies, 3,288 people: improves. Efficacy of Probiotics in the Management of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
- Meta-analysis, 2022; 13 studies; healthy adults: no clear difference.
No improvement in abdominal pain and bloating was found.
Effects of Bifidobacterium animalis subspecies lactis supplementation on gastrointestinal symptoms: systematic review with meta-analysis - Randomised trial, 2026; 350 people; healthy individuals with self-reported bloating or indigestion: improves.
Bloating and gas were reduced in the synbiotic arm
A Randomized, Placebo-Controlled Trial Evaluating Multi-Species Synbiotic Supplementation for Bloating, Gas, and Abdominal Discomfort - Crossover trial, 2026; 25 people; healthy adults: no clear difference. A high-fibre snack containing Lacticaseibacillus rhamnosus GG for healthy adults: a randomised, double-blind, placebo-controlled crossover trial
- Randomised trial, 2023; 125 people; patients with functional abdominal bloating: improves.
patients in the probiotic group had a significantly lower frequency of abdominal bloating
Evaluation and comparison of therapeutic effects of probiotics and colloidal bismuth subcitrate on abdominal bloating
- Systematic review, 2013; 37 studies; adults with lower gastrointestinal symptoms: improves (the review the verdict rests on).
Key findings
- Intestinal MotilityImproves (the measure goes up)
- Fecal WeightImproves (the measure goes down)
- Constipation Signs and SymptomsImproves (the measure goes down)
The Digestive Health (General GI Support) protocol
2 primary supplements · 5 supporting supplements
- Probiotics (Multi-strain)10–50 billion CFU daily (Lactobacillus, Bifidobacterium strains)
- Psyllium Fiber5–10 g daily with plenty of water
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
The supplements graded A or B for Digestive Health. Each opens third-party tested products for that supplement.
- Grade A
- Grade A
- Grade B
- Grade B
- Grade B
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
2 studies from PubMed